Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$618M |
| 2 |
HES
Hess
HES
|
+$564M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$342M |
| 4 |
Deere & Co
DE
|
+$296M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$626M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$483M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$473M |
| 4 |
VMW
VMware, Inc
VMW
|
+$366M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.2% |
| 2 | Industrials | 8.98% |
| 3 | Consumer Discretionary | 7.34% |
| 4 | Financials | 7.07% |
| 5 | Healthcare | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Americold
COLD
$4.39B
| $16.8M | 0.03% |
+555,183
| New | +$15.5M |
|
652
PUT
Insmed
INSM
$27.1B
| $16.8M | 0.03% |
541,600
+9,600
| +2% | +$249K |
|
653
Rio Tinto
RIO
$170B
| $16.7M | 0.03% |
+224,541
| New | +$15.1M |
|
654
CALL
ExxonMobil
XOM
$672B
| $16.7M | 0.03% |
167,200
-85,800
| -34% | -$9.02M |
|
655
Domino's
DPZ
$11.4B
| $16.6M | 0.03% |
40,384
+38,233
| +1,777% | +$14.3M |
|
656
IDEAYA Biosciences
IDYA
$3.88B
| $16.6M | 0.03% |
+466,271
| New | +$13.9M |
|
657
PUT
Nasdaq
NDAQ
$55B
| $16.6M | 0.03% |
+285,000
| New | +$15M |
|
658
ARK Innovation ETF
ARKK
$6.43B
| $16.5M | 0.03% |
316,015
+278,335
| +739% | +$12.1M |
|
659
SITE Centers
SITC
$162M
| $16.5M | 0.03% |
1,556,238
-3,548,479
| -70% | -$35.4M |
|
|
660
ExxonMobil
XOM
$672B
| $16.5M | 0.03% |
165,101
-420,350
| -72% | -$44.2M |
|
661
PUT
Aflac
AFL
$59.1B
| $16.5M | 0.03% |
200,000
| – | – |
|
662
CALL
Meta Platforms (Facebook)
META
$1.42T
| $16.5M | 0.03% |
46,600
-36,200
| -44% | -$11.8M |
|
663
Waters Corp
WAT
$40.1B
| $16.5M | 0.03% |
49,989
+48,689
| +3,745% | +$13.4M |
|
664
CoStar Group
CSGP
$13.2B
| $16.5M | 0.03% |
188,264
+183,937
| +4,251% | +$14.9M |
|
665
Revolution Medicines
RVMD
$45B
| $16.3M | 0.03% |
567,105
-395,552
| -41% | -$9.5M |
|
666
Guidewire Software
GWRE
$15.9B
| $16.3M | 0.03% |
149,138
-283,764
| -66% | -$27.1M |
|
667
IDEX
IEX
$17.2B
| $16.2M | 0.03% |
74,831
-725,863
| -91% | -$146M |
|
668
PUT
Microchip Technology
MCHP
$40B
| $16.2M | 0.03% |
180,100
-164,900
| -48% | -$13.4M |
|
669
Embecta
EMBC
$281M
| $16.2M | 0.03% |
857,891
-631,980
| -42% | -$10.4M |
|
670
PUT
Gilead Sciences
GILD
$182B
| $16.2M | 0.03% |
200,300
+36,300
| +22% | +$2.82M |
|
671
CALL
Live Nation Entertainment
LYV
$43B
| $16.1M | 0.03% |
172,500
+141,500
| +456% | +$12.2M |
|
672
Itron
ITRI
$4.32B
| $16.1M | 0.03% |
213,541
+210,230
| +6,349% | +$13.7M |
|
|
SWAV
673
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $16M | 0.03% |
+84,014
| New | +$15.9M |
|
|
PHYT
674
DELISTED
Pyrophyte Acquisition Corp.
PHYT
| $15.9M | 0.03% |
1,442,387
| – | – |
|
675
Devon Energy
DVN
$52.8B
| $15.8M | 0.03% |
348,426
-380,023
| -52% | -$17.4M |
|
Similar funds
Dmitry Balyasny's Q4 2023 Portfolio in Review
As of Q4 2023, Dmitry Balyasny held 3,055 positions worth $53.3B, up 8.7% from $49B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Dmitry Balyasny withdrew a net $1.7B in Q4 2023, closing 627 positions and reducing 736 holdings. Its most notable exit was Activision Blizzard, an estimated $626M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, down from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in Invesco S&P 500 Equal Weight ETF worth $671M.
- Dmitry Balyasny's largest Q4 2023 buy was Invesco S&P 500 Equal Weight ETF: 4,254,702 shares worth $671M.
- Dmitry Balyasny added most to Hess in Q4 2023, an estimated $564M increase.
- Dmitry Balyasny's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $473M.
- Dmitry Balyasny fully exited Activision Blizzard in Q4 2023, selling an estimated $626M.
- Dmitry Balyasny's ten largest holdings make up 13% of its $53.3B portfolio in Q4 2023.
- Dmitry Balyasny opened 851 new positions and closed 627 in Q4 2023.
- Dmitry Balyasny's portfolio value rose 8.7% quarter-over-quarter to $53.3B.
Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.